The development of end-point assays to assess the safety and efficacy of intra-pulmonary gene therapy in cystic fibrosis
Main Author: | Davies, Michael Gordon |
---|---|
Published: |
Imperial College London
2009
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.520985 |
Similar Items
-
Pulmonary colonisation of patients with cystic fibrosis by Burkholderia cepacia
by: Butler, Sarah Louise
Published: (1994) -
Blood monocytes in cystic fibrosis
by: Rao, Satish Ramakrishna
Published: (2009) -
Lung infection in cystic fibrosis
by: Hurley, Matthew
Published: (2016) -
The use of impedance pH measurements to determine the effect of gastro-oesophageal reflux in patients with idiopathic pulmonary fibrosis and cystic fibrosis
by: Krishnan, Amaran
Published: (2014) -
Investigation of the role of glucose in airway secretions in the pathogenesis of pulmonary decline in cystic fibrosis related diabetes
by: Brennan, Amanda L.
Published: (2011)